FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Lidothol Patch Recall

Lidothol Patch, Lidocaine 4

Preferred Pharmaceuticals, Inc. · Anaheim, CA

Risk level
Class II
Reported by FDA
Jul 22, 2020
Recall ID
D-1390-2020
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Lidothol Patch starting Jul 1, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1390-2020 on Jul 22, 2020. Reason: CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch. Status: Terminated.

Why it was recalled

CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.

Product description

Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical analgesic, Pkg Size 15 patches per box, Insurance NDC: 53225-1025-01, Mfg: Terrain Pharmaceuticals; Reno, NV, Prod # (NDC): 68788-7405-01, Preferred Pharmaceuticals, Inc., The Physicians Solutions.

Lot numbers, UPCs & expiration codes

Lot Numbers: H0218Z, H1518J, I2018L, J2918C, L1018Q, A0419M, G0519G; Exp: 5/31/2021.

Where it was sold

Nationwide within the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1390-2020
Classification
Class II
Status
Terminated
Recall initiated
Jul 1, 2020
FDA report date
Jul 22, 2020
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1390-2020, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
86002
Address
1250 N Lakeview Ave Ste O
Code information
Lot Numbers: H0218Z, H1518J, I2018L, J2918C, L1018Q, A0419M, G0519G; Exp: 5/31/2021.
Postal code
92807-1801
Report date
Jul 22, 2020
Product type
Drugs
Recall number
D-1390-2020
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc.
Termination date
Apr 17, 2024
Reason for recall
CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical analgesic, Pkg Size 15 patches per box, Insurance NDC: 53225-1025-01, Mfg: Terrain Pharmaceuticals; Reno, NV, Prod # (NDC): 68788-7405-01, Preferred Pharmaceuticals, Inc., The Physicians Solutions.
Distribution pattern
Nationwide within the U.S.
Recall initiation date
Jul 1, 2020
Initial firm notification
Letter
Center classification date
Jul 15, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1390-2020, published Jul 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls